Clinical Trial

A Study to Evaluate Efficacy and Safety of HCP1803-4 in Patients With Essential Hypertension

Name: A Study to Evaluate Efficacy and Safety of HCP1803-4 in Patients With Essential Hypertension — clinical trial record (NCT07660796)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-06-16.

Trial Details

NCT Number	NCT07660796
Lead Sponsor	Hanmi Pharmaceutical Company Limited
Conditions	Hypertension
Enrollment	256 participants
Start Date	2026-07-06
Primary Completion	2027-10-30 (estimated)
Study Completion	2027-11-30 (estimated)
Updated on ClinicalTrials.gov	2026-06-30